Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)

Completed · Not applicable

Conditions studied: ASCVD, Coronary Artery Calcification

In brief

Estimate the impact of notifying both patients and their clinicians of the presence of incidental coronary artery calcium (CAC) on initiation of lipid-lowering therapy in patients with ASCVD who are not receiving lipid-lowering therapy.

Key facts

Study ID

NCT05858879

Run by

Stanford University

People needed

233

Starts

2024-10-22

Expected to finish

2026-03-24

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presence of CAC on non-gated chest CT scans performed from 2021 to 2025
• Age <85 years
• Diagnosis of ASCVD(coronary artery disease, peripheral artery disease, or cerebrovascular disease)
• Visit to Stanford affiliated clinician since 2022 at one of the following Stanford clinics including University affiliated clinics:
• Internal Medicine
• Family Medicine
• Cardiology
• Neurology
• Vascular surgery
• Primary language is English or Spanish

You may not qualify if…

• No diagnosis of ASCVD
• Patients receiving lipid-lowering therapy
• Dementia
• Metastatic cancer or active cancer undergoing chemotherapy
• Hospice

Where it is running

• Stanford University — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.